Cyclavance 100 mg/ml oral solution for dogs and cats
Cyclavance 100 mg/ml oral solution for dogs and cats
Authorised
- Ciclosporin
Product identification
Medicine name:
Cyclavance 100 mg/ml oral solution for dogs and cats
Cyclavance 100 mg/ml Drank
Cyclavance 100 mg/ml Solution buvable
Cyclavance 100 mg/ml Lösung zum Einnehmen
Active substance:
- Ciclosporin
Target species:
-
Dog
-
Cat
Route of administration:
-
Oral use
Product details
Active substance and strength:
-
Ciclosporin100.00milligram(s)1.00millilitre(s)
Pharmaceutical form:
-
Oral solution
Withdrawal period by route of administration:
-
Oral use
- Dog
- Cat
Anatomical therapeutic chemical veterinary (ATCvet) codes:
- QL04A
Legal status of supply:
-
Veterinary medicinal product subject to veterinary prescription
Authorisation status:
-
Valid
Authorised in:
-
Belgium
Package description:
- Amber glass (type III) bottles closed with a 20 mm bromobutyl stopper and an aluminum cap with flip-off.50 ml bottle, with two dispenser sets consisting of a polycarbonate dispenser capwith a silicone valve and both 1 ml and 3 ml polypropylene oral syringes graduated in increments of respectively 0.05 ml and 0.1 ml, packaged in a cardboard box.
- Amber glass (type III) bottles closed with a 20 mm bromobutyl stopper and an aluminum cap with flip-off.30 ml bottle, with two dispenser sets consisting of a polycarbonate dispenser capwith a silicone valve and both 1 ml and 3 ml polypropylene oral syringes graduated in increments of respectively 0.05 ml and 0.1 ml, packaged in a cardboard box.
- Amber glass (type III) bottles closed with a 20 mm bromobutyl stopper and an aluminum cap with flip-off.15 ml bottle with a dispenser set consisting of a polycarbonate dispenser cap with asilicone valve and a 1 ml polypropylene oral syringe graduated in increments of 0.05 mL, packaged in a cardboard box.
- Amber glass (type III) bottles closed with a 20 mm bromobutyl stopper and an aluminum cap with flip-off.5 ml bottle with a dispenser set consisting of a polycarbonate dispenser cap with asilicone valve and a 1 ml polypropylene oral syringe graduated in increments of 0.05 ml, packaged in a cardboard box.
- Amber glass (type III) bottles closed with a child resistant HDPE screw cap including aplastic adapter (HDPE).60 ml bottle, with two dispenser sets consisting of both 1 ml and 2 ml PE oralsyringes graduated in increments of respectively 0.05 ml and 0.1 ml, packaged in a cardboard box.
- Amber glass (type III) bottles closed with a child resistant HDPE screw cap including aplastic adapter (HDPE).30 ml bottle, with two dispenser sets consisting of both 1 ml and 2 ml PE oralsyringes graduated in increments of respectively 0.05 ml and 0.1 ml, packaged in a cardboard box.
- Amber glass (type III) bottles closed with a child resistant HDPE screw cap including aplastic adapter (HDPE).15 ml bottle, with a dispenser set consisting of a 1 ml PE oral syringe graduated inincrements of 0.05 ml, packaged in a cardboard box.
- Amber glass (type III) bottles closed with a child resistant HDPE screw cap including aplastic adapter (HDPE).5 ml bottle, with a dispenser set consisting of a 1 ml PE oral syringe graduated inincrements of 0.05 ml, packaged in a cardboard box.
Additional information
Entitlement type:
-
Marketing Authorisation
Legal basis of product authorisation:
-
Generic application (Article 13(1) of Directive No 2001/82/EC)
Marketing authorisation holder:
- Virbac
Marketing authorisation date:
Manufacturing sites for batch release:
- Labiana Life Sciences S.A.
Responsible authority:
- Federal Agency For Medicines And Health Products
Authorisation number:
This information is not available for this product.
Date of authorisation status change:
Reference member state:
-
Ireland
Procedure number:
- IE/V/0523/001
Concerned member states:
-
Austria
-
Belgium
-
Bulgaria
-
Cyprus
-
Czechia
-
Denmark
-
Estonia
-
Finland
-
France
-
Germany
-
Greece
-
Hungary
-
Italy
-
Latvia
-
Lithuania
-
Luxembourg
-
Netherlands
-
Norway
-
Poland
-
Portugal
-
Romania
-
Slovakia
-
Slovenia
-
Spain
-
Sweden
-
United Kingdom (Northern Ireland)
To consult adverse reactions on veterinary medicinal products please go to www.adrreports.eu/vet
Documents
Package Leaflet
This document does not exist in this language (English). You can find it in another language below.
Labelling
This document does not exist in this language (English). You can find it in another language below.
How useful was this page?: